Results 181 to 190 of about 823,617 (410)
Response by Steinberg et al to Letter Regarding Article, “Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2A Study” [PDF]
Gary K. Steinberg +2 more
openalex +1 more source
Transplantation tolerance, microchimerism, and the two-way paradigm [PDF]
Demetris, AJ, Starzl, TE
core +1 more source
Cytokine‐engineered CAR‐T cells represent a promising immunotherapy against malignancies due to direct tumor killing and potent immunity response. However, significant toxicities, including CRS and ICANS, have restricted clinical applications. How to keep the risk‐benefit balance of the advanced therapy is of great importance for maximizing the benefit
Xinru Zhang +7 more
wiley +1 more source
Therapeutic application of EUS-guided intraportal autologous bone marrow transplantation for decompensated liver cirrhosis. [PDF]
Cai T +9 more
europepmc +1 more source
Whole bone marrow transplantation induces angiogenesis following acute ischemia [PDF]
Reida El Oakley +6 more
openalex +1 more source
Resilient Calvarial Bone Marrow Supports Retinal Repair in Type 2 Diabetes
Skull bone (calvarium) marrow in diabetic mice stay structurally intact and keeps making blood cells, unlike the bone marrow of the leg bones. The skull marrow is exposed to cerebrospinal fluid (CSF), which contains protective molecules called oxysterols.
Bright Asare‐Bediako +16 more
wiley +1 more source
AI-driven prognostics in pediatric bone marrow transplantation: a CAD approach with Bayesian and PSO optimization. [PDF]
Badawy M +7 more
europepmc +1 more source
Cytoplasmic RNF32 fuels CRC liver metastasis by degrading GSK3β, which stabilizes β‐catenin and activates Wnt/EMT. Moreover, RNF32 rewires the metastatic niche: it depletes CD8+/CD4+ T and NK cells while recruiting SPP1+ macrophages (which boost tumor stemness via CD44), fibroblasts, and immunosuppressive monocytes to aid colonization.
Hongyu Wang +12 more
wiley +1 more source

